Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Cash from Investing Activities of -$22.1 million for Q2 2026, up 91.33% year-over-year from -$11.5 million in Q2 2025, and up 95.35% quarter-over-quarter from -$475.3 million in Q1 2026.
Koninklijke Philips (PHG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$22.1 million for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 91.33% year-over-year to -$22.1 million; the TTM figure through Jun 2026 stood at -$2.0 billion (down 28.02% YoY), while the FY2025 annual figure was -$857.9 million, down 40.11% from the prior year.
- Cash from Investing Activities for Q2 2026 stood at -$22.1 million, up from -$475.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$22.1 million in Q2 2026, with the low at -$1.5 billion in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$497.9 million (2026), against an average of -$531.0 million.
- Peak annual rise in Cash from Investing Activities reached 91.33% in 2026, while the deepest fall reached 187.82% in 2026.
- Koninklijke Philips' Cash from Investing Activities stood at -$1.5 billion in 2022, then surged by 54.89% to -$684.3 million in 2023, then climbed by 10.52% to -$612.3 million in 2024, then tumbled by 40.11% to -$857.9 million in 2025, then surged by 97.43% to -$22.1 million in 2026.
- Business Quant data shows PHG's Cash from Investing Activities at -$22.1 million in Q2 2026, -$475.3 million in Q1 2026, and -$857.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.08 Mn |
| Jun 30, 2026 | -22.08 Mn |
| Mar 31, 2026 | -475.32 Mn |
| Mar 31, 2026 | -475.32 Mn |
| Dec 31, 2025 | -857.90 Mn |
| Dec 31, 2025 | -857.90 Mn |
| Sep 30, 2025 | -632.46 Mn |
| Sep 30, 2025 | -632.46 Mn |
| Jun 30, 2025 | -254.69 Mn |
| Jun 30, 2025 | -254.69 Mn |
| Mar 31, 2025 | -165.15 Mn |
| Mar 31, 2025 | -165.15 Mn |
| Dec 31, 2024 | -612.31 Mn |
| Dec 31, 2024 | -612.31 Mn |
| Sep 30, 2024 | -520.56 Mn |
| Sep 30, 2024 | -520.56 Mn |
| Jun 30, 2024 | -175.53 Mn |
| Jun 30, 2024 | -175.53 Mn |
| Mar 31, 2024 | -190.11 Mn |
| Mar 31, 2024 | -190.11 Mn |